We conclude that homozygous MTAP-deleted primary GBM tumors do not selectively exhibit significant elevation of MTA as opposed of what was reported in vitro, a conclusion supported by both our own results and corroborated by public domain data. The gene discussed is MTAP; the disease is glioblastoma.